- Open Access
Tumor grade of clear cell renal cell carcinoma assessed by contrast-enhanced computed tomography
© Ishigami et al.; licensee Springer. 2014
- Received: 19 August 2014
- Accepted: 19 November 2014
- Published: 26 November 2014
The purpose of this study was to clarify the association between CT findings and Fuhrman grade of clear cell renal cell carcinoma (ccRCC). The study group consisted of 214 surgically proven ccRCC in 214 patients. Contrast-enhanced CT studies were retrospectively assessed for tumor size, cystic versus solid, calcification, heterogeneity of lesions, percentage of non-enhancing (necrotic) areas, and growth pattern. CT findings and Fuhrman grade were compared. Nineteen of 22 (86.4%) cystic ccRCC were low grade (Fuhrman grades 1-2). There was no significant correlation between tumor size and grade in cystic ccRCC (P = 0.43). In predominantly solid ccRCC, there was significant correlation between tumor size and grade (P < 0.0001). Thirty-eight of 43 (88.4%) infiltrative ccRCC were high grade (Fuhrman grades 3-4). Logistic regression showed tumor size and infiltrative growth were significantly associated with grades 3-4 (P = 0.00083 and P = 0.0059). Cystic ccRCC tends to be low grade. Infiltrative growth and larger tumor size may increase the likelihood of high grade ccRCC.
- Clear cell renal cell carcinoma
- Computed tomography
- Fuhrman grade
- Cystic renal cell carcinoma
- Growth pattern
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of RCC, accounting for approximately 70 - 80% of RCC (Leibovich et al.2010; Teloken et al.2009; Kim et al.2002). It has a poorer prognosis than other subtypes of RCC, such as papillary and chromophobe RCC (Leibovich et al.2010; Teloken et al.2009), and its biological aggressiveness significantly affects prognosis.
The system most widely employed to classify RCC is the Fuhrman grading system, which uses the characteristics of the nuclei and nucleoli of tumor cells as its basis for grading (Fuhrman et al.1982; Novara et al.2007; Ficarra et al.2005). Fuhrman grade 1 is the least aggressive type, with grade 4 being the most aggressive (Fuhrman et al.1982). Grades 1–2 and 3–4 are classified as low and high grades, respectively (Novara et al.2007; Ficarra et al.2005). Higher grade tumors have an elevated risk of postoperative recurrence (Novara et al.2007); thus, postoperative surveillance for these patients should be more rigorous. The Fuhrman grade is one of the most effective parameters used in predicting the biological aggressiveness and metastatic potential of ccRCC and papillary RCC (Novara et al.2007; Sukov et al.2012; Nishikimi et al.2011), although it lacks prognostic significance for chromophobe RCC (Cheville et al.2012).
Imaging assessment of tumor grades in RCC may aid in clinical management decisions. For example, less invasive procedures (e.g., nephron-sparing surgery and radiofrequency ablation) or close observation may be considered for low grade RCC.
There have been few previous reports citing use of magnetic resonance imaging (MRI) to compare Fuhrman grade with imaging characteristics, and the number of cases reported was relatively small (Vargas et al.2013; Goyal et al.2012; Rosenkrantz et al.2010). Computed tomography (CT) is most often used for preoperative evaluation of RCC, and image quality is generally similar across institutions. Therefore, CT may be more applicable in evaluating significant numbers of cases.
The purpose of this study was to clarify the association between contrast-enhanced CT findings and Fuhrman grade of ccRCC.
This retrospective study was approved by the Institutional Review Board in the University of Iowa Hospitals and Clinics and informed consent was waived.
A computerized search of the pathology and radiology database at our institution found 235 cases of clear cell renal cell carcinoma (ccRCC) that had undergone computed tomography (CT) between November 2007 and November 2012. Five cases that had only unenhanced CT were excluded, as well nine biopsy proven cases (as tumor grade from the biopsy specimen may not be identical to the actual tumor grade (Novara et al.2007). Six cases of mixed clear cell and papillary (n = 5) and chromophobe (n = 1) RCC were also excluded because the biological aggressiveness is different. Additionally, one multiple ccRCC case was excluded because the tumor grades of each nodule were difficult to correlate. In cases of multifocal ccRCC, the largest lesion was evaluated to avoid the bias when performing the statistical analysis. The study group therefore consisted of 214 patients with 214 ccRCC that had undergone surgical resection and preoperative contrast-enhanced CT studies. One case was multilocular cystic RCC, a variant of ccRCC with an excellent prognosis (Suzigan et al.2006; You et al.2011; Hindman et al.2012).
The patient group consisted of 138 males and 76 females. The ages ranged from 25 to 86 years old (mean ± standard deviation [SD]: 58 ± 13 years old). There were 102 ccRCCs found in the right kidney and 112 in the left kidney. Of these, 9 were classified as Fuhrman grade 1, 107 grade 2, 72 grade 3, and 26 grade 4 ccRCC. Fuhrman grade was determined by the attending pathologists who were blind to radiology findings. Because Fuhrman grades were obtained from pathology reports, pathologists did not re-evaluate the pathology specimens.
Contrast-enhanced CT protocols and CT units were somewhat variable, as the study group recruited spanned a five-year period. All examinations were performed with multi-detector row CT equipped with 4, 16, or 64 detector rows. Non-ionic intravenous contrast (300, 320, 350, or 370 mgI/mL) was administered at 94 ml to 152 ml. The venous phase was obtained in 209 cases, including 94 late corticomedullary differentiation nephrographic and 115 homogeneous nephrographic phases. In the five cases where venous phase was not available, the early corticomedullary differentiation nephrographic (arterial) phase was available for review. The early corticomedullary differentiation nephrographic and delayed (excretory) phases were performed in 45 and 171 cases, respectively. Section thickness was 2, 3, or 5 mm. In addition, coronal and sagittal multiplanar reformatted (MPR) images were available for review in 190 cases.
CT studies were retrospectively reviewed by an experienced body imaging radiologist who had 18 years of experience. The reviewer knew the diagnosis of RCC but was blinded to the Fuhrman grade. MPR images were utilized if they were available. The reviewer measured the maximum diameter of the tumor size (if MPR images were available, they were utilized for the measurements). The measurements were performed twice on separate days and average data was recorded. Presence or absence of calcification was also recorded.
Tumors were classified as either cystic or predominantly solid. Cystic ccRCC was diagnosed if the tumor consisted of more than 75% of unilocular or multilocular fluid-filled non-enhancing component (Beddy et al.2014; Koga et al.2000; Han et al.2004; Hartman et al.1986) with a recognizable outer wall and/or internal septations. When an irregular solid component was circumferential, it was considered as ccRCC with central necrosis rather than cystic ccRCC. Cystic ccRCCs were classified using the Bosniak classification system (Israel & Bosniak2005). Predominantly solid ccRCCs were classified into three types based on tumor margins: (1) well-circumscribed (expansive tumor growth with well-circumscribed and round tumor margin); (2) lobulated (lobulated tumor contour with well-defined tumor margin); or (3) infiltrative (indistinct border between the tumor and normal kidney).
Tumor enhancement for predominantly solid ccRCC was further classified as either homogenous and heterogeneous. In addition, the proportion of the non-enhancing (necrotic) area within the predominantly solid ccRCC was classified as 0 - 20%, 20 - 40%, 40 - 60%, and 60% or more.
Fuhrman grades and imaging findings were compared using the Fisher’s exact test and the Kruskal-Wallis exact test. Tumor size was compared using the Student-t or Welch t-test. The correlation between the tumor grade and size was assessed by Spearman’s rank correlation. In addition, the receiver operating characteristic (ROC) curve was fit to determine the cut-off value for tumor size in the diagnosis of Fuhrman grades. Finally, logistic regression was utilized to find significant variables that would suggest Fuhrman grades 3–4 and grade 4 RCC, respectively.
All statistical analyses were performed using EZR (Saitama Medical Centre, Jichi Medical University;http://www.jichi.ac.jp/saitama-sct/SaitamaHP.files/statmedEN.html; Kanda, 2012), a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria, version 2.13.0). More precisely, EZR is a modified version of R Commander (version 1.6-3), designed to add statistical functions frequently used in biostatistics (Kanda2013). All P-values were two sided, and P-values of less than 0.05 were considered statistically significant.
Fuhrman grades of clear cell renal cell carcinoma (ccRCC) in each morphology
Tumor size of ccRCC in each morphology
Mean ± standard deviation
1.3 - 7.7
4.1 ± 1.5
1.1 - 13.4
3.9 ± 2.1
4.2 - 14.5
8.0 ± 2.6
3.8 – 17.2
10.7 ± 3.0
Receiver operating characteristic (ROC) curves showed the cut-off value of 5.0 cm in the diagnosis of Fuhrman grades 3-4 ccRCC. The sensitivity, specificity, and the area under the ROC curve were 69.4%, 69.8%, and 0.740, respectively.
Imaging findings of ccRCC
≥ 20%, <40%
≥ 40%, <60%
Univariate analysis of imaging findings of ccRCC and Fuhrman grades
Calcification* +/- (n = 214)
Tumor heterogeneity Homo/Hetero (n = 192)
Non-enhancing area† ≥60%/<60% (n = 192)
Multivariate (logistic regression) analysis in the diagnosis of Fuhrman grades 3–4 ccRCC
1.1 – 1.4
1.6 – 15.4
0.3 – 2.5
0.9 – 27.7
Non-enhancing area ≥60%
0.7 – 3.9
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of RCC, followed by papillary and chromophobe RCCs. Characteristics of ccRCC are possible to differentiate from papillary and chromophobe RCCs on diagnostic imaging (Kim et al.2002), although it is not 100% accurate. Because papillary RCC is generally more indolent than ccRCC (Leibovich et al.2010; Teloken et al.2009), and Fuhrman grade lacks prognostic significance for chromophobe RCC (Cheville et al.2012), papillary and chromophobe RCCs were not considered in this study. Oncocytoma, a less common benign renal tumor, was beyond the scope of this study because it can be difficult to prospectively differentiate it from ccRCC on diagnostic imaging. For these reasons, we focused solely on the imaging findings of ccRCC and their relationship to Fuhrman grade.
In our study, cystic ccRCC was more likely (88.5%) to be low grade (Fuhrman grades 1–2), and no correlation was found between the size of cystic ccRCC and Fuhrman grade (Figure 6a). These results were in keeping with previous studies that showed cystic RCC to have a better prognosis than solid RCC (Koga et al.2000; Han et al.2004) and can be explained by the fact that fewer malignant cells are present in cystic RCC than predominantly solid RCC. Our results suggest that less invasive procedures such as nephron-sparing surgery or close observation may be considered for cystic RCC.
Our study did include a small percentage of high grade (Fuhrman grades 3–4) cystic ccRCC, although it was not statistically significant by multivariate analysis. RCC with cystic necrosis has the worst prognosis among the cystic RCCs (Han et al.2004; Hartman et al.1986), and one previous study showed the presence of tumor necrosis correlated with aggressive histology (Beddy et al.2014). Distinguishing cystic ccRCC from ccRCC with extensive central necrosis can be a problematic in some cases, although we did not evaluate interobserver variability on this study. When ccRCC is equivocal for solid or cystic type, it is recommended that the type be considered predominantly solid to avoid underestimation.
The increased likelihood of high grade tumors in infiltrative ccRCC (88.4%) may reflect biological tumor aggressiveness (Figure 3). For example, RCCs with aggressive histology, such as type 2 papillary RCC (Yamada et al.2008; Rosenkrantz et al.2013) and collecting duct RCC (Yoon et al.2006), commonly show an infiltrative appearance on imaging. Similarly, it has been reported that a histopathological finding of infiltrative growth was a factor indicating poor prognosis in ccRCC (Nishikimi et al.2011). Our results suggest that careful post-operative surveillance may be necessary for RCC with infiltrative growth on imaging findings.
The association of larger tumor size with higher grade, stage and metastasis has been described in previous reports (Umbreit et al.2012; Zhang et al.2012). However, it should be recognized that there can be some overlap in CT findings between Fuhrman grades 2 and 3 ccRCC.
Calcification and 60% or more non-enhancing area were commonly present in large tumors, which may explain why these findings were not significant by multivariate analysis in our study. In addition, one previous study showed that decreased tumor vascularity was associated with high grade RCCs (Vargas et al.2013). Because the CT protocols of our study group varied somewhat, our ability to evaluate tumor enhancement may have been limited. Further study to clarify the association between tumor neo-vascularity in ccRCC and tumor grade may be necessary.
The limitations of this study include 1) a retrospective study at a single institution, 2) non-uniform CT acquisition techniques, 3) no correlation of CT findings with histopathology results except Fuhrman grade of ccRCC, 4) a retrospective review of CT findings by a single experienced radiologist without assessment of interobserver variability, 5) inclusion of surgically proved clear cell RCC only and exclusion of other primary renal neoplasms, and 6) Fuhrman grades obtained from pathology reports without re-review.
In summary, cystic ccRCC tended to be low grade (Fuhrman grades 1–2), and tumor size did not correlate with tumor grade. For predominantly solid ccRCC, infiltrative growth and larger tumor size may increase the likelihood of high grade ccRCC (Fuhrman grades 3–4).
The author would like to thank Edmund A. Franken Jr., M.D. and Nichole Jenkins, M.A., Department of Radiology University of Iowa Hospitals & Clinics for their assistance in editing this manuscript.
- Beddy P, Genega EM, Ngo L, Hindman N, Wei J, Bullock A, Bhatt RS, Atkins MB, Pedrosa I: Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. Clin Genitourin Cancer 2014, 12: 55-62. 10.1016/j.clgc.2013.07.006View ArticleGoogle Scholar
- Cheville JC, Lohse CM, Sukov WR, Thompson RH, Leibovich BC: Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Am J Surg Pathol 2012, 36: 851-856. 10.1097/PAS.0b013e3182496895View ArticleGoogle Scholar
- Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, Zanolla L, Pea M, Artibani W: Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 2005, 103: 68-75. 10.1002/cncr.20749View ArticleGoogle Scholar
- Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6: 655-663. 10.1097/00000478-198210000-00007View ArticleGoogle Scholar
- Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A, Iyer VK, Das P: Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Acta Radiol 2012, 53: 349-358. 10.1258/ar.2011.110415View ArticleGoogle Scholar
- Han KR, Janzen NK, McWhorter VC, Kim HL, Pantuck AJ, Zisman A, Figlin RA, Dorey FJ, Said JW, Belldegrun AS: Cystic renal cell carcinoma: biology and clinical behavior. Urol Oncol 2004, 22: 410-414. 10.1016/S1078-1439(03)00173-XView ArticleGoogle Scholar
- Hartman DS, Davis CJ Jr, Johns T, Goldman SM: Cystic renal cell carcinoma. Urology 1986, 28: 145-153. 10.1016/0090-4295(86)90109-3View ArticleGoogle Scholar
- Hindman NM, Bosniak MA, Rosenkrantz AB, Lee-Felker S, Melamed J: Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings. AJR Am J Roentgenol 2012, 198: W20-W26. 10.2214/AJR.11.6762View ArticleGoogle Scholar
- Israel GM, Bosniak MA: An update of the Bosniak renal cyst classification system. Urology 2005, 66: 484-488. 10.1016/j.urology.2005.04.003View ArticleGoogle Scholar
- Kanda Y: Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013, 48: 452-458. 10.1038/bmt.2012.244View ArticleGoogle Scholar
- Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS: Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 2002, 178: 1499-1506. 10.2214/ajr.178.6.1781499View ArticleGoogle Scholar
- Koga S, Nishikido M, Hayashi T, Matsuya F, Saito Y, Kanetake H: Outcome of surgery in cystic renal cell carcinoma. Urology 2000, 56: 67-70. 10.1016/S0090-4295(00)00540-9View ArticleGoogle Scholar
- Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, Cheville JC: Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 2010, 183: 1309-1315. 10.1016/j.juro.2009.12.035View ArticleGoogle Scholar
- Nishikimi T, Tsuzuki T, Fujita T, Sassa N, Fukatsu A, Katsuno S, Yoshino Y, Hattori R, Gotoh M: The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases. Pathol Int 2011, 61: 116-121. 10.1111/j.1440-1827.2010.02633.xView ArticleGoogle Scholar
- Novara G, Martignoni G, Artibani W, Ficarra V: Grading systems in renal cell carcinoma. J Urol 2007, 177: 430-436. 10.1016/j.juro.2006.09.034View ArticleGoogle Scholar
- Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J: Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 2010, 195: W344-W351. 10.2214/AJR.10.4688View ArticleGoogle Scholar
- Rosenkrantz AB, Sekhar A, Genega EM, Melamed J, Babb JS, Patel AD, Lo A, Najarian RM, Ahmed M, Pedrosa I: Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma. Eur Radiol 2013, 23: 579-587. 10.1007/s00330-012-2631-yView ArticleGoogle Scholar
- Sukov WR, Lohse CM, Leibovich BC, Thompson RH, Cheville JC: Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. J Urol 2012, 187: 54-59. 10.1016/j.juro.2011.09.053View ArticleGoogle Scholar
- Suzigan S, López-Beltrán A, Montironi R, Drut R, Romero A, Hayashi T, Gentili AL, Fonseca PS, de Torres I, Billis A, Japp LC, Bollito E, Algaba F, Requena-Tapias MJ: Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol 2006, 125: 217-222. 10.1309/AH6F-C77P-YR2V-6YAYView ArticleGoogle Scholar
- Teloken PE, Thompson RH, Tickoo SK, Cronin A, Savage C, Reuter VE, Russo P: Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol 2009, 182: 2132-2136. 10.1016/j.juro.2009.07.019View ArticleGoogle Scholar
- Umbreit EC, Shimko MS, Childs MA, Lohse CM, Cheville JC, Leibovich BC, Blute ML, Thompson RH: Metastatic potential of a renal mass according to original tumour size at presentation. BJU Int 2012, 109: 190-194. 10.1111/j.1464-410X.2011.10184.xView ArticleGoogle Scholar
- Vargas HA, Delaney HG, Delappe EM, Wang Y, Zheng J, Moskowitz CS, Tan Y, Zhao B, Schwartz LH, Hricak H, Russo P, Akin O: Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 2013, 37: 1160-1167. 10.1002/jmri.23899View ArticleGoogle Scholar
- Yamada T, Endo M, Tsuboi M, Matsuhashi T, Takase K, Higano S, Takahashi S: Differentiation of pathologic subtypes of papillary renal cell carcinoma on CT. AJR Am J Roentgenol 2008, 191: 1559-1563. 10.2214/AJR.07.3181View ArticleGoogle Scholar
- Yoon SK, Nam KJ, Rha SH, Kim JK, Cho KS, Kim B, Kim KH, Kim KA: Collecting duct carcinoma of the kidney: CT and pathologic correlation. Eur J Radiol 2006, 57: 453-460. 10.1016/j.ejrad.2005.09.009View ArticleGoogle Scholar
- You D, Shim M, Jeong IG, Song C, Kim JK, Ro JY, Hong JH, Ahn H, Kim CS: Multilocular cystic renal cell carcinoma: clinicopathological features and preoperative prediction using multiphase computed tomography. BJU Int 2011, 108: 1444-1449. 10.1111/j.1464-410X.2011.10247.xView ArticleGoogle Scholar
- Zhang C, Li X, Hao H, Yu W, He Z, Zhou L: The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases. BJU Int 2012, 110: E481-E485. 10.1111/j.1464-410X.2012.11173.xView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.